Ca V 1.2 and Ca V 1.3 Channel Hyperactivation in Mouse Islet Β Cells Exposed to Type 1 Diabetic Serum

Guang Yang,Yue Shi,Jia Yu,Yuxin Li,Lina Yu,Andrea Welling,Franz Hofmann,Jörg Striessnig,Lisa Juntti-Berggren,Per-Olof Berggren,Shao-Nian Yang
DOI: https://doi.org/10.1007/s00018-014-1737-6
IF: 8
2014-01-01
Cellular and Molecular Life Sciences
Abstract:The voltage-gated Ca 2+ (Ca V ) channel acts as a key player in β cell physiology and pathophysiology. β cell Ca V channels undergo hyperactivation subsequent to exposure to type 1 diabetic (T1D) serum resulting in increased cytosolic free Ca 2+ concentration and thereby Ca 2+ -triggered β cell apoptosis. The present study was aimed at revealing the subtypes of Ca V 1 channels hyperactivated by T1D serum as well as the biophysical mechanisms responsible for T1D serum-induced hyperactivation of β cell Ca V 1 channels. Patch-clamp recordings and single-cell RT-PCR analysis were performed in pancreatic β cells from Ca V 1 channel knockout and corresponding control mice. We now show that functional Ca V 1.3 channels are expressed in a subgroup of islet β cells from Ca V 1.2 knockout mice (Ca V 1.2 −/− ). T1D serum enhanced whole-cell Ca V currents in islet β cells from Ca V 1.3 knockout mice (Ca V 1.3 −/− ). T1D serum increased the open probability and number of functional unitary Ca V 1 channels in Ca V 1.2 −/− and Ca V 1.3 −/− β cells. These data demonstrate that T1D serum hyperactivates both Ca V 1.2 and Ca V 1.3 channels by increasing their conductivity and number. These findings suggest Ca V 1.2 and Ca V 1.3 channels as potential targets for anti-diabetes therapy.
What problem does this paper attempt to address?